Arthur J. Higgins
2019 - DepoMed
In 2019, Arthur J. Higgins earned a total compensation of $4.9M as President and Chief Executive Officer at DepoMed, a 2% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $793,040 |
---|---|
Salary | $800,000 |
Stock Awards | $3,267,209 |
Other | $9,120 |
Total | $4,869,369 |
Higgins received $3.3M in stock awards, accounting for 67% of the total pay in 2019.
Higgins also received $793K in non-equity incentive plan, $800K in salary and $9.1K in other compensation.
Rankings
In 2019, Arthur J. Higgins' compensation ranked 2,294th out of 13,971 executives tracked by ExecPay. In other words, Higgins earned more than 83.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,294 | 84th |
Manufacturing | 828 | 86th |
Chemicals And Allied Products | 264 | 88th |
Drugs | 212 | 89th |
Pharmaceutical Preparations | 155 | 89th |
Higgins' colleagues
We found two more compensation records of executives who worked with Arthur J. Higgins at DepoMed in 2019.
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019